4-46312576-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000807.4(GABRA2):​c.396A>G​(p.Lys132Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.421 in 1,595,942 control chromosomes in the GnomAD database, including 145,514 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 11580 hom., cov: 32)
Exomes 𝑓: 0.43 ( 133934 hom. )

Consequence

GABRA2
NM_000807.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.110

Publications

123 publications found
Variant links:
Genes affected
GABRA2 (HGNC:4076): (gamma-aminobutyric acid type A receptor subunit alpha2) GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
GABRA2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 78
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 4-46312576-T-C is Benign according to our data. Variant chr4-46312576-T-C is described in ClinVar as Benign. ClinVar VariationId is 1168077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.11 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.508 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000807.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA2
NM_000807.4
MANE Select
c.396A>Gp.Lys132Lys
synonymous
Exon 5 of 10NP_000798.2
GABRA2
NM_001330690.2
c.396A>Gp.Lys132Lys
synonymous
Exon 5 of 11NP_001317619.1
GABRA2
NM_001377144.1
c.396A>Gp.Lys132Lys
synonymous
Exon 5 of 11NP_001364073.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA2
ENST00000381620.9
TSL:1 MANE Select
c.396A>Gp.Lys132Lys
synonymous
Exon 5 of 10ENSP00000371033.4
GABRA2
ENST00000515082.5
TSL:1
c.396A>Gp.Lys132Lys
synonymous
Exon 5 of 9ENSP00000423840.1
GABRA2
ENST00000507069.5
TSL:3
c.396A>Gp.Lys132Lys
synonymous
Exon 4 of 10ENSP00000427603.1

Frequencies

GnomAD3 genomes
AF:
0.378
AC:
57479
AN:
151908
Hom.:
11565
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.253
Gnomad AMI
AF:
0.382
Gnomad AMR
AF:
0.449
Gnomad ASJ
AF:
0.305
Gnomad EAS
AF:
0.524
Gnomad SAS
AF:
0.241
Gnomad FIN
AF:
0.415
Gnomad MID
AF:
0.341
Gnomad NFE
AF:
0.436
Gnomad OTH
AF:
0.373
GnomAD2 exomes
AF:
0.404
AC:
95718
AN:
237012
AF XY:
0.397
show subpopulations
Gnomad AFR exome
AF:
0.249
Gnomad AMR exome
AF:
0.504
Gnomad ASJ exome
AF:
0.307
Gnomad EAS exome
AF:
0.518
Gnomad FIN exome
AF:
0.416
Gnomad NFE exome
AF:
0.427
Gnomad OTH exome
AF:
0.404
GnomAD4 exome
AF:
0.425
AC:
613714
AN:
1443916
Hom.:
133934
Cov.:
31
AF XY:
0.419
AC XY:
300932
AN XY:
718114
show subpopulations
African (AFR)
AF:
0.239
AC:
7764
AN:
32530
American (AMR)
AF:
0.492
AC:
20160
AN:
41004
Ashkenazi Jewish (ASJ)
AF:
0.313
AC:
7947
AN:
25426
East Asian (EAS)
AF:
0.486
AC:
19029
AN:
39136
South Asian (SAS)
AF:
0.242
AC:
20167
AN:
83174
European-Finnish (FIN)
AF:
0.418
AC:
22220
AN:
53160
Middle Eastern (MID)
AF:
0.275
AC:
1563
AN:
5674
European-Non Finnish (NFE)
AF:
0.444
AC:
490409
AN:
1104286
Other (OTH)
AF:
0.411
AC:
24455
AN:
59526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
15424
30847
46271
61694
77118
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14790
29580
44370
59160
73950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.378
AC:
57511
AN:
152026
Hom.:
11580
Cov.:
32
AF XY:
0.379
AC XY:
28136
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.252
AC:
10480
AN:
41510
American (AMR)
AF:
0.449
AC:
6849
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.305
AC:
1056
AN:
3466
East Asian (EAS)
AF:
0.524
AC:
2701
AN:
5154
South Asian (SAS)
AF:
0.241
AC:
1162
AN:
4826
European-Finnish (FIN)
AF:
0.415
AC:
4383
AN:
10572
Middle Eastern (MID)
AF:
0.356
AC:
104
AN:
292
European-Non Finnish (NFE)
AF:
0.436
AC:
29644
AN:
67936
Other (OTH)
AF:
0.372
AC:
784
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1795
3589
5384
7178
8973
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
548
1096
1644
2192
2740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.377
Hom.:
8250
Bravo
AF:
0.383
Asia WGS
AF:
0.368
AC:
1279
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GABRA2-related disorder Benign:1
Oct 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
5.7
DANN
Benign
0.63
PhyloP100
-0.11
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs279858; hg19: chr4-46314593; COSMIC: COSV62914124; API